Treatment or prevention of herpes simplex virus retinitis with intravitreally injectable crystalline 1-O-hexadecylpropanediol-3-phospho-ganciclovir

Investigative Ophthalmology and Visual Science

Volumn 43, Issue 2, 2002, Pages 515-521

  Cheng, Lingyun ^a   Hostetler, Karl Y ^a   Chaidhawangul, Sunan ^a   Gardner, Michael F ^a   Beadle, James R ^a   Toyoguchi, Mitsuko ^a   Bergeron Lynn, Germaine ^a   Freeman, William R ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 O HEXADECYLPROPANEDIOL 3 PHOSPHOGANCICLOVIR; GANCICLOVIR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATARACT; CONTROLLED STUDY; DOSE RESPONSE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; ELECTRORETINOGRAPHY; HERPES SIMPLEX VIRUS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NONHUMAN; OPHTHALMOSCOPY; PRIORITY JOURNAL; RABBIT; RETINA DISEASE; RETINITIS; SLOW RELEASE FORMULATION;

ANIMALS; BIOLOGICAL AVAILABILITY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CRYSTALLIZATION; DRUG DELIVERY SYSTEMS; ELECTRORETINOGRAPHY; EYE INFECTIONS, VIRAL; GANCICLOVIR; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; INJECTIONS; PRODRUGS; RABBITS; RETINITIS; SAFETY; VITREOUS BODY;

EID: 0036156959     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. High dose intravitreal foscarnet in the treatment of cytomegalovirus retinitis in AIDS
2. Efficacy and tolerance of intravitreal ganciclovir in cytomegalovirus retinitis in acquired immune deficiency syndrome
3. High-dose (2000-microgram) intravitreous ganciclovir in the treatment of cytomegalovirus retinitis
4. Treatment of cytomegalovirus retinitis with intravitreous cidofovir in patients with AIDS: A preliminary report
5. Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implant: A randomized controlled clinical trial
6. Antibiotic selection in the treatment of endophthalmitis: The significance of drug combinations and synergy
7. Ganciclovir implant exchange: Timing, surgical procedure, and complications
8. Intravitreal toxicology in rabbits of two preparations of 1-O-octadecyl-sn-glycerol-3-phosphonoformate, a sustained-delivery anti-CMV drug
9. Intravitreal toxicology and duration of efficacy of a novel antiviral lipid prodrug of ganciclovir in liposome formulation
10. Treatment of herpes retinitis in an animal model with a sustained delivery antiviral drug, liposomal 1-O-octadecyl-SN-glycerol-3-phosphonoformate
11. Rod photoresponses in 6-week and 4-month-old human infants
12. Distribution of ERG amplitudes, latencies, and implicit times
13. Intravitreal pharmacokinetics in rabbits of the foscarnet lipid prodrug: 1-O-octadecyl-sn-glycerol-3-phosphonoformate (ODG-PFA)
14. Intravitreal triamcinolone acetonide in exudative age-related macular degeneration
15. Pharmacokinetics of the ganciclovir implant in the silicone-filled eye
16. Long-acting therapy of viral retinitis with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)-cytosine